Cisplatin resistant NSCLC sublines representing large cell, adenocarcinoma and squamous cell carcinoma subtypes displayed significantly greater ALDH1 activity compared to their corresponding parental controls. This evidence concerns the gene ALDH1A1 and adenocarcinoma.